% IMPORTANT: The following is UTF-8 encoded.  This means that in the presence
% of non-ASCII characters, it will not work with BibTeX 0.99 or older.
% Instead, you should use an up-to-date BibTeX implementation like “bibtex8” or
% “biber”.

@INPROCEEDINGS{Lohmann:910521,
      author       = {Lohmann, Philipp},
      title        = {{C}ombining advanced {MRI} and {PET}},
      reportid     = {FZJ-2022-03904},
      year         = {2022},
      abstract     = {ABSTRACTNeuroimaging techniques such as magnetic resonance
                      imaging (MRI) and positron emission tomography (PET) provide
                      valuable diagnostic information in the follow-up of patients
                      with glioma. Particularly PET using radiolabeled amino
                      acids, advanced MRI techniques such as perfusion-weighted
                      imaging, diffusion-weighted imaging or MR spectroscopy, and
                      combinations thereof demonstrated their potential for a
                      non-invasive assessment of biological characteristics of
                      brain cancer. Considering the growing complexity of
                      neuroimaging data, advanced statistical methods from the
                      field of artificial intelligence such as radiomics play an
                      important role for clinical decision-making and have the
                      potential to significantly impact diagnosis and response
                      assessment in neuro-oncology. Further, the increasing
                      availability of hybrid PET/MRI systems and the advent of
                      ultra-high field MRI scanners operating at magnetic field
                      strengths of 7 Tesla or more opens new possibilities for
                      improvements in metabolic imaging. The presentation
                      summarizes the status of advanced MRI and PET, highlights
                      the latest developments and methodological advancements, and
                      envisions the future role of advanced neuroimaging in the
                      follow-up of patients with glioma.},
      month         = {Jun},
      date          = {2022-06-25},
      organization  = {EAN 2022 – Vienna, Vienna (Austria),
                       25 Jun 2022 - 25 Jun 2022},
      cin          = {INM-4},
      cid          = {I:(DE-Juel1)INM-4-20090406},
      pnm          = {5253 - Neuroimaging (POF4-525)},
      pid          = {G:(DE-HGF)POF4-5253},
      typ          = {PUB:(DE-HGF)1},
      url          = {https://juser.fz-juelich.de/record/910521},
}